China’s elites are stockpiling supplies of Paxlovid, Pfizer’s Covid-19 antiviral drug, and giving it away to curry favor with business associates as an unprecedented Covid wave leaves hospitals stripped of resources and ordinary people struggling to access medication.
Multiple public and private hospitals told the Financial Times that the drug, the only foreign Covid medication approved for use in China, was either out of stock or only available to patients with severe underlying health conditions. Paxlovid is generally prescribed to treat mild to moderate Covid cases. Read More